Market cap
₹179 Cr
Revenue (TTM)
₹46 Cr
P/E Ratio
60
P/B Ratio
13.7
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -59.43 | 414.46 | 151.64 | 445.22 | 362.10 |
| EBIT | -25.47 | 1,640.21 | 286.99 | 136.52 | 33.28 |
| Net Profit | -23.43 | 1,638.89 | 209.51 | 268.12 | 78.41 |
| EPS | -23.46 | 1,644.90 | 209.70 | 155.88 | 61.79 |
| Book Value | -- | -- | 392.07 | 68.41 | 38.80 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-24 | Mar-23 |
| EBIT-Margin
| -138.81 | -349.66 | 8.41 | 0.78 | -216.96 |
| Net Margin
| 3.77 | -130.40 | 6.43 | 1.41 | 6.77 |
| Return on equity
| 1.15 | 0.69 | 27.23 | 3.44 | 0.00 |
| Return on Capital
| 0.85 | 0.51 | -- | 2.54 | 0.00 |
| Return on Assets
| 9.84 | -126.67 | 12.31 | 1.84 | 22.31 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.00 | -0.73 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
--
|
2.54
|
--
|
--
|
--
|
|
Peer Median
|
--
|
16.46
|
15.49
|
17.37
|
17.62
|
ROE
27.23
Higher than Peers by 17.29
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
27.23
|
3.44
|
--
|
--
|
--
|
|
Peer Median
|
9.94
|
13.87
|
14.72
|
15.70
|
18.36
|
ROA
12.31
Higher than Peers by 5.06
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
12.31
|
1.84
|
22.31
|
5.37
|
-664.44
|
|
Peer Median
|
7.26
|
8.04
|
7.19
|
9.43
|
9.43
|
EBIT Margin
8.41
Lower than Peers by 1.14
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
8.41
|
0.78
|
-216.96
|
-200.24
|
-982.24
|
|
Peer Median
|
9.55
|
10.05
|
10.28
|
13.90
|
17.27
|
Net Margin
6.43
Lower than Peers by 2.21
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
6.43
|
1.41
|
6.77
|
3.12
|
-532.90
|
|
Peer Median
|
8.64
|
9.11
|
6.78
|
10.91
|
12.99
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
--
|
1.43
|
23.62
|
9.78
|
-911.24
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
151.64
Higher than Peers by 145.40
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
151.64
|
3,231.11
|
668.88
|
95.67
|
--
|
|
Peer Median
|
6.24
|
7.17
|
10.56
|
12.63
|
15.47
|
EBIT Growth
286.99
Higher than Peers by 287.05
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
286.99
|
111.90
|
-733.08
|
60.11
|
-2,133.24
|
|
Peer Median
|
-0.06
|
12.05
|
6.17
|
-2.90
|
51.73
|
Net Profit Growth
209.51
Higher than Peers by 201.93
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
209.51
|
101.63
|
1,757.47
|
102.10
|
--
|
|
Peer Median
|
7.58
|
22.15
|
27.97
|
-14.10
|
44.15
|
EPS Growth
209.70
Higher than Peers by 207.51
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
209.70
|
-12.74
|
1,766.67
|
102.09
|
--
|
|
Peer Median
|
2.18
|
8.80
|
--
|
-3.68
|
38.52
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
--
|
775.00
|
4.67
|
0.25
|
-13.57
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
--
|
--
|
-0.73
|
-0.84
|
-0.79
|
|
Peer Median
|
0.02
|
0.03
|
0.05
|
0.14
|
0.23
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
--
|
--
|
-0.23
|
-0.36
|
-0.31
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.47
Lower than Peers by 1.98
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
0.47
|
40.77
|
0.10
|
0.05
|
0.02
|
|
Peer Median
|
2.45
|
2.20
|
1.93
|
1.82
|
1.75
|
Quick Ratio
0.47
Lower than Peers by 1.25
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
0.47
|
40.77
|
0.10
|
0.03
|
0.02
|
|
Peer Median
|
1.72
|
1.72
|
1.59
|
1.30
|
1.04
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
--
|
237.71
|
1,108.59
|
144.19
|
--
|
|
Peer Median
|
9.71
|
12.28
|
12.45
|
16.98
|
15.07
|
Operating Efficiency
Debtors to sales
13.69
Lower than Peers by 13.22
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
13.69
|
--
|
--
|
--
|
--
|
|
Peer Median
|
26.91
|
26.23
|
23.97
|
24.57
|
20.26
|
Asset Turnover
1.91
Higher than Peers by 1.23
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
1.91
|
1.29
|
0.94
|
0.55
|
0.73
|
|
Peer Median
|
0.67
|
0.74
|
0.88
|
0.82
|
0.79
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
--
|
--
|
--
|
96.48
|
96.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
--
|
14.62
|
765.47
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
--
|
-14.62
|
-765.47
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
59.96
Higher than Peers by 4.17
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
59.96
|
135.74
|
93.33
|
--
|
--
|
|
Peer Median
|
55.79
|
39.17
|
40.74
|
25.97
|
33.71
|
Price / Book Value
13.71
Higher than Peers by 9.23
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
13.71
|
1.99
|
-4.57
|
--
|
--
|
|
Peer Median
|
4.48
|
3.61
|
3.87
|
2.79
|
4.36
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.14
|
0.19
|
0.20
|
0.65
|
0.28
|
EV/EBITDA
43.67
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
43.67
|
78.68
|
78.78
|
1,889.18
|
-52.90
|
|
Peer Median
|
--
|
28.79
|
25.41
|
15.07
|
23.32
|
Market Cap
179
Lower than Peers by 5,282
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gujarat Inject
|
179
|
11
|
4
|
--
|
--
|
|
Peer Median
|
5,461
|
3,944
|
2,959
|
3,742
|
6,050
|